TECLens Closes $10 Million Series A2 Extension Financing to Advance Proof-of-Concept Study for Non-Invasive Vision Correction Technology August 25, 2026 Learn More »
First Patient Treated in TECLens First-in-Human Clinical Study of Revolutionary Non-Invasive Vision Correction Technology February 24, 2026 Learn More »
TECLens Quantitative Corneal Cross-Linking (qCXL™) Debuted in the U.S. for the First Time November 4, 2025 Learn More »
TECLens Secures $9.3 Million Series A Funding to Advance Its Non-Invasive Refractive Technology February 11, 2025 Learn More »
